Drug · DIN 02487292
AIMOVIG
PREFILLED SYRINGE
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since April 11, 2019.
- Drug Identification Number (DIN)
- 02487292
- Company (DIN owner)
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Schedule
- Prescription; Schedule d
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Erenumab N02CD01
- Class
- Human
- Record last updated
- July 31, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ERENUMAB | 140 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 11, 2019: NOC 22056Supplement to a New Drug Submission (SNDS) · New strength
Other DINs named AIMOVIG
- DIN 02479613 · Marketed
- DIN 02487306 · Marketed
- DIN 02479605 · Approved